Methodological consensus on clinical proton MRS of the brain: Review and recommendations.

Szczegóły
Abstrakt

Tytuł:: Methodological consensus on clinical proton MRS of the brain: Review and recommendations.
Autorzy:: Wilson M; Centre for Human Brain Health and School of Psychology, University of Birmingham, Birmingham, England.
Andronesi O; Martinos Center for Biomedical Imaging, Department of Radiology, Massachusetts General Hospital, Harvard Medical School, Boston, Massachusetts.
Barker PB; Department of Radiology, Johns Hopkins University School of Medicine, Baltimore, Maryland.
Bartha R; Robarts Research Institute, University of Western Ontario, London, Canada.
Bizzi A; U.O. Neuroradiologia, Fondazione IRCCS Istituto Neurologico Carlo Besta, Milano, Italy.
Bolan PJ; Department of Radiology, Center for Magnetic Resonance Research, University of Minnesota, Minneapolis, Minnesota.
Brindle KM; Department of Biochemistry, University of Cambridge, Cambridge, England.
Choi IY; Department of Neurology, Hoglund Brain Imaging Center, University of Kansas Medical Center, Kansas City, Kansas.
Cudalbu C; Center for Biomedical Imaging, Ecole Polytechnique Federale de Lausanne, Lausanne, Switzerland.
Dydak U; School of Health Sciences, Purdue University, West Lafayette, Indiana.
Emir UE; School of Health Sciences, Purdue University, West Lafayette, Indiana.
Gonzalez RG; Department of Radiology, Massachusetts General Hospital, Harvard Medical School, Boston, Massachusetts.
Gruber S; High Field MR Center, Department of Biomedical imaging and Image-Guided Therapy, Medical University of Vienna, Vienna, Austria.
Gruetter R; Laboratory for Functional and Metabolic Imaging, Center for Biomedical Imaging, Ecole Polytechnique Federale de Lausanne, Lausanne, Switzerland.
Gupta RK; Fortis Memorial Research Institute, Gurugram, Haryana, India.
Heerschap A; Department of Radiology and Nuclear Medicine, Radboud University Medical Center, Nijmegen, the Netherlands.
Henning A; Max Planck Institute for Biological Cybernetics, Tuebingen, Germany.
Hetherington HP; Department of Radiology, University of Pittsburgh, Pittsburgh, Pennsylvania.
Huppi PS; Department of Pediatrics, University of Geneva, Geneva, Switzerland.
Hurd RE; Stanford Radiological Sciences Lab, Stanford, California.
Kantarci K; Department of Radiology, Mayo Clinic, Rochester, Minnesota.
Kauppinen RA; School of Psychological Science, University of Bristol, Bristol, England.
Klomp DWJ; University Medical Centre Utrecht, Utrecht, the Netherlands.
Kreis R; Departments of Radiology and Biomedical Research, University of Bern, Bern, Switzerland.
Kruiskamp MJ; Philips Healthcare, Best, the Netherlands.
Leach MO; CRUK Cancer Imaging Centre, Institute of Cancer Research and Royal Marsden Hospital, London, England.
Lin AP; Center for Clinical Spectroscopy, Brigham and Women's Hospital, Harvard University Medical School, Boston, Massachusetts.
Luijten PR; University Medical Centre Utrecht, Utrecht, the Netherlands.
Marjańska M; Department of Radiology, Center for Magnetic Resonance Research, University of Minnesota, Minneapolis, Minnesota.
Maudsley AA; Department of Radiology, University of Miami, Miami, Florida.
Meyerhoff DJ; DVA Medical Center and Department of Radiology and Biomedical Imaging, University of California San Francisco, San Francisco, California.
Mountford CE; Translational Research Institute, Woolloongabba, Australia.
Mullins PG; Bangor Imaging Unit, School of Psychology, Bangor University, Bangor, Wales.
Murdoch JB; Canon Medical Research USA, Mayfield Village, Ohio.
Nelson SJ; Department of Radiology and Biomedical Imaging, University of California San Francisco, San Francisco, California.
Noeske R; GE Healthcare, Berlin, Germany.
Öz G; Department of Radiology, Center for Magnetic Resonance Research, University of Minnesota, Minneapolis, Minnesota.
Pan JW; Department of Neurology, University of Pittsburgh, Pittsburgh, Pennsylvania.
Peet AC; Institute of Cancer and Genomic Sciences, University of Birmingham, Birmingham, England.
Poptani H; Centre for Preclinical Imaging, Institute of Translational Medicine, University of Liverpool, Liverpool, England.
Posse S; Department of Neurology, University of New Mexico, Albuquerque, New Mexico.
Ratai EM; Martinos Center for Biomedical Imaging, Department of Radiology, Massachusetts General Hospital, Harvard Medical School, Boston, Massachusetts.
Salibi N; MR R&D, Siemens Healthineers, Malvern, Pennsylvania.
Scheenen TWJ; Department of Radiology and Nuclear Medicine, Radboud University Medical Center, Nijmegen, the Netherlands.
Smith ICP; Innovative Biodiagnostics, Winnipeg, Canada.
Soher BJ; Department of Radiology, Duke University Medical Center, Durham, North Carolina.
Tkáč I; Department of Radiology, Center for Magnetic Resonance Research, University of Minnesota, Minneapolis, Minnesota.
Vigneron DB; Department of Radiology and Biomedical Imaging, University of California San Francisco, San Francisco, California.
Howe FA; Molecular and Clinical Sciences, St George's University of London, London, England.
Źródło:: Magnetic resonance in medicine [Magn Reson Med] 2019 Aug; Vol. 82 (2), pp. 527-550. Date of Electronic Publication: 2019 Mar 28.
Typ publikacji:: Journal Article; Review
Język:: English
Imprint Name(s):: Publication: 1999- : New York, NY : Wiley
Original Publication: San Diego : Academic Press,
MeSH Terms:: Brain/*diagnostic imaging
Magnetic Resonance Imaging/*methods
Brain/metabolism ; Consensus ; Humans ; Protons
References:: Magn Reson Med. 1998 Dec;40(6):816-21. (PMID: 9840825)
Magn Reson Med. 2000 Jan;43(1):23-33. (PMID: 10642728)
Comput Biol Med. 2001 Jul;31(4):269-86. (PMID: 11334636)
NMR Biomed. 2004 Oct;17(6):361-81. (PMID: 15468083)
Neuroimage. 2018 Mar;168:71-87. (PMID: 28602943)
Magn Reson Med. 2015 Jun;73(6):2081-6. (PMID: 25046769)
Eur J Radiol. 2008 Aug;67(2):230-239. (PMID: 18434063)
Magn Reson Med. 2017 Aug;78(2):441-451. (PMID: 27604395)
Magn Reson Med. 2002 Apr;47(4):629-33. (PMID: 11948722)
Magn Reson Med. 2011 Oct;66(4):911-22. (PMID: 21469184)
Magn Reson Imaging. 2006 Dec;24(10):1295-302. (PMID: 17145400)
Neurology. 2013 Feb 12;80(7):610-5. (PMID: 23325907)
NMR Biomed. 2012 Dec;25(12):1392-400. (PMID: 22714729)
Anal Biochem. 2017 Jul 15;529:17-29. (PMID: 27293215)
J Magn Reson Imaging. 2016 Aug;44(2):411-9. (PMID: 26756662)
Radiology. 1994 Sep;192(3):733-8. (PMID: 8058941)
NMR Biomed. 2005 Feb;18(1):1-13. (PMID: 15660450)
Magn Reson Med. 2011 Apr;65(4):901-10. (PMID: 21413056)
NMR Biomed. 2000 May;13(3):129-53. (PMID: 10861994)
Ann N Y Acad Sci. 1987;508:333-48. (PMID: 3326459)
Magn Reson Med. 2007 Dec;58(6):1107-16. (PMID: 17968995)
NMR Biomed. 2010 Dec;23(10):1117-26. (PMID: 20954198)
Magn Reson Med. 2017 Jan;77(1):411-421. (PMID: 26822475)
Magn Reson Med. 2008 Jan;59(1):40-51. (PMID: 18050349)
NMR Biomed. 2015 Jul;28(7):923-4. (PMID: 26094860)
NMR Biomed. 2018 Nov;31(11):e3929. (PMID: 30168205)
Magn Reson Med. 2000 Feb;43(2):319-23. (PMID: 10680699)
Magn Reson Med. 2018 Sep;80(3):851-863. (PMID: 29388313)
J Magn Reson. 2013 Apr;229:187-97. (PMID: 23453759)
Magn Reson Med. 2015 May;73(5):1718-25. (PMID: 24948590)
Magn Reson Med. 2005 Feb;53(2):465-9. (PMID: 15678549)
Brain Behav. 2013 May;3(3):229-42. (PMID: 23785655)
J Magn Reson B. 1994 May;104(1):1-10. (PMID: 8025810)
J Magn Reson Imaging. 2014 Jan;39(1):224-34. (PMID: 23559504)
NMR Biomed. 2008 Jan;21(1):33-41. (PMID: 17347991)
Nat Rev Clin Oncol. 2017 Mar;14(3):169-186. (PMID: 27725679)
MAGMA. 2008 Mar;21(1-2):95-101. (PMID: 18210177)
Magn Reson Imaging. 1992;10(2):315-9. (PMID: 1564998)
Magn Reson Med. 2008 May;59(5):989-98. (PMID: 18429025)
Magn Reson Med. 2013 May;69(5):1253-60. (PMID: 22745036)
J Magn Reson Imaging. 2014 Jul;40(1):181-91. (PMID: 24395184)
Magn Reson Med. 1996 May;35(5):678-87. (PMID: 8722819)
Magn Reson Med. 1991 Jan;17(1):82-94. (PMID: 1648655)
Magn Reson Med. 1991 Jul;20(1):113-22. (PMID: 1943653)
Magn Reson Med. 1991 Apr;18(2):335-47. (PMID: 2046515)
Magn Reson Med. 2019 May;81(5):2878-2886. (PMID: 30417937)
Magn Reson Med. 1984 Sep;1(3):370-86. (PMID: 6571566)
NMR Biomed. 2006 Jun;19(4):492-503. (PMID: 16763967)
Magn Reson Med. 2009 Mar;61(3):533-40. (PMID: 19097232)
Magn Reson Med. 1995 Jan;33(1):34-40. (PMID: 7891533)
Magn Reson Med. 2016 Jan;75(1):15-8. (PMID: 25753153)
Magn Reson Imaging. 2007 Oct;25(8):1148-54. (PMID: 17905247)
Magn Reson Med. 2016 Feb;75(2):488-97. (PMID: 25762370)
AJNR Am J Neuroradiol. 2006 Apr;27(4):895-901. (PMID: 16611787)
Int J Biomed Imaging. 2013;2013:169526. (PMID: 23970895)
Magn Reson Med. 2000 Oct;44(4):537-45. (PMID: 11025509)
Magn Reson Med. 1989 Jan;9(1):79-93. (PMID: 2540396)
NMR Biomed. 2010 Apr;23(3):251-6. (PMID: 19777506)
Magn Reson Med. 2006 May;55(5):1164-9. (PMID: 16596629)
Magn Reson Med. 2003 Feb;49(2):223-32. (PMID: 12541241)
Magn Reson Med. 1997 Nov;38(5):834-9. (PMID: 9358459)
Magn Reson Med. 2015 Jan;73(1):44-50. (PMID: 24436292)
Magn Reson Med. 2005 Nov;54(5):1268-72. (PMID: 16187272)
Magn Reson Med. 2003 Jan;49(1):19-28. (PMID: 12509816)
Magn Reson Med. 1999 Apr;41(4):649-56. (PMID: 10332839)
Radiology. 2012 Feb;262(2):647-61. (PMID: 22187628)
Magn Reson Imaging. 2009 Nov;27(9):1249-57. (PMID: 19766422)
J Magn Reson. 2001 Dec;153(2):155-77. (PMID: 11740891)
Magn Reson Med. 2016 Oct;76(4):1083-91. (PMID: 26502373)
Phys Med Biol. 1985 Apr;30(4):341-4. (PMID: 4001160)
Magn Reson Med. 1993 Dec;30(6):672-9. (PMID: 8139448)
Magn Reson Med. 1993 Jun;29(6):804-11. (PMID: 8350724)
Magn Reson Med. 1996 Oct;36(4):637-42. (PMID: 8892219)
Magn Reson Med. 2008 Jun;59(6):1457-66. (PMID: 18421692)
Magn Reson Med. 2004 Nov;52(5):1207-13. (PMID: 15508170)
Eur Radiol. 2007 Jul;17(7):1651-62. (PMID: 17235536)
Magn Reson Med. 2010 Apr;63(4):881-91. (PMID: 20373389)
Magn Reson Med. 2013 Apr;69(4):920-30. (PMID: 22692829)
Magn Reson Med. 1990 Nov;16(2):192-225. (PMID: 2266841)
J Magn Reson. 2008 Nov;195(1):67-75. (PMID: 18789736)
J Alzheimers Dis. 2012;31 Suppl 3:S101-15. (PMID: 22543852)
Magn Reson Med. 2008 Jan;59(1):1-6. (PMID: 17969076)
Proc Natl Acad Sci U S A. 1982 Jun;79(11):3523-6. (PMID: 6954498)
Radiology. 2014 Mar;270(3):658-79. (PMID: 24568703)
Nat Med. 2012 Jan 26;18(4):624-9. (PMID: 22281806)
J Magn Reson Imaging. 2013 Jun;37(6):1301-25. (PMID: 23188775)
Magn Reson Med. 2001 Oct;46(4):713-22. (PMID: 11590648)
Magn Reson Med. 2015 Aug;74(2):320-9. (PMID: 25168657)
Magn Reson Imaging. 2010 Apr;28(3):305-13. (PMID: 20045600)
ACS Chem Neurosci. 2018 Jan 17;9(1):130-137. (PMID: 29035503)
Magn Reson Med. 1996 Sep;36(3):462-8. (PMID: 8875419)
NMR Biomed. 2016 May;29(5):563-75. (PMID: 27071355)
Med Phys. 2002 Sep;29(9):2177-97. (PMID: 12349940)
Magn Reson Med. 2009 Oct;62(4):868-79. (PMID: 19591201)
Magn Reson Med. 2013 Jun;69(6):1501-11. (PMID: 22807147)
Magn Reson Med. 2015 Oct;74(4):915-24. (PMID: 25264976)
Magn Reson Med. 1998 Sep;40(3):376-82. (PMID: 9727940)
NMR Biomed. 2015 Jun;28(6):685-93. (PMID: 25904240)
Magn Reson Med. 2001 Oct;46(4):706-12. (PMID: 11590647)
Magn Reson Med. 1997 Jun;37(6):858-65. (PMID: 9178236)
Magn Reson Med. 1990 Apr;14(1):26-30. (PMID: 2161984)
NMR Biomed. 2015 Mar;28(3):306-16. (PMID: 25581510)
Anal Biochem. 2017 Jul 15;529:98-116. (PMID: 28115170)
Magn Reson Med. 2017 Jan;77(1):23-33. (PMID: 26715192)
MAGMA. 2008 Mar;21(1-2):121-30. (PMID: 18259791)
Magn Reson Med. 2015 Nov;74(5):1209-20. (PMID: 25354190)
NMR Biomed. 2018 Mar;31(3):. (PMID: 29315915)
Magn Reson Med. 2012 Oct;68(4):1007-17. (PMID: 22213108)
Magn Reson Med. 1998 Dec;40(6):812-5. (PMID: 9840824)
NMR Biomed. 2016 Oct;29(10):1381-90. (PMID: 27455374)
Magn Reson Med. 2007 Aug;58(2):236-44. (PMID: 17610279)
J Magn Reson Imaging. 2005 Mar;21(3):317-22. (PMID: 15723370)
Magn Reson Med. 2006 Jun;55(6):1219-26. (PMID: 16688703)
Magn Reson Med. 2003 Dec;50(6):1296-301. (PMID: 14648578)
Magn Reson Med. 1999 Dec;42(6):1082-8. (PMID: 10571929)
Magn Reson Med. 2018 Mar;79(3):1241-1250. (PMID: 28618085)
Magn Reson Med. 2018 Feb;79(2):1145-1156. (PMID: 28543722)
J Magn Reson Imaging. 2010 Jan;31(1):61-70. (PMID: 20027568)
Neurology. 2005 Feb 8;64(3):434-41. (PMID: 15699371)
Magn Reson Med. 2008 Jun;59(6):1274-81. (PMID: 18506793)
Magn Reson Med. 2011 Jan;65(1):1-12. (PMID: 20878762)
Grant Information:: 16465 United Kingdom CRUK_ Cancer Research UK; R01 NS080816 United States NS NINDS NIH HHS; 17242 United Kingdom CRUK_ Cancer Research UK; P30 NS076408 United States NS NINDS NIH HHS; R01 EB024408 United States EB NIBIB NIH HHS; U54 HD090216 United States HD NICHD NIH HHS; 28667 United Kingdom CRUK_ Cancer Research UK; 16464 United Kingdom CRUK_ Cancer Research UK
Contributed Indexing:: Keywords: MRS; brain; consensus; metabolites; semi-LASER; shimming
Substance Nomenclature:: 0 (Protons)
Entry Date(s):: Date Created: 20190329 Date Completed: 20200511 Latest Revision: 20240328
Update Code:: 20240329
PubMed Central ID:: PMC7179569
DOI:: 10.1002/mrm.27742
PMID:: 30919510
: Czasopismo naukowe

Full Text Finder

Proton MRS ( 1 H MRS) provides noninvasive, quantitative metabolite profiles of tissue and has been shown to aid the clinical management of several brain diseases. Although most modern clinical MR scanners support MRS capabilities, routine use is largely restricted to specialized centers with good access to MR research support. Widespread adoption has been slow for several reasons, and technical challenges toward obtaining reliable good-quality results have been identified as a contributing factor. Considerable progress has been made by the research community to address many of these challenges, and in this paper a consensus is presented on deficiencies in widely available MRS methodology and validated improvements that are currently in routine use at several clinical research institutions. In particular, the localization error for the PRESS localization sequence was found to be unacceptably high at 3 T, and use of the semi-adiabatic localization by adiabatic selective refocusing sequence is a recommended solution. Incorporation of simulated metabolite basis sets into analysis routines is recommended for reliably capturing the full spectral detail available from short TE acquisitions. In addition, the importance of achieving a highly homogenous static magnetic field (B 0 ) in the acquisition region is emphasized, and the limitations of current methods and hardware are discussed. Most recommendations require only software improvements, greatly enhancing the capabilities of clinical MRS on existing hardware. Implementation of these recommendations should strengthen current clinical applications and advance progress toward developing and validating new MRS biomarkers for clinical use.
(© 2019 International Society for Magnetic Resonance in Medicine.)

Informacja